BL-7010

BioLineRx, Ltd. · Phase 1 active Small molecule

At a glance

Generic name	BL-7010
Also known as	BL7010
Sponsor	BioLineRx, Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BL-7010 CI brief — competitive landscape report
BL-7010 updates RSS · CI watch RSS
BioLineRx, Ltd. portfolio CI